Ulvac Inc
TSE:6728
Ulvac Inc
TSE:6728
Price:
6 077
JPY
0.4%
Market Cap:
300B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Ulvac Inc
6077
+24 (+0.4%)
| 52 Week Range |
5 969
11 285
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Ulvac Inc
Balance Sheet
Balance Sheet Decomposition
Ulvac Inc
Ulvac Inc
| Current Assets | 260B |
| Cash & Short-Term Investments | 91.6B |
| Receivables | 89.7B |
| Other Current Assets | 78.7B |
| Non-Current Assets | 107.4B |
| Long-Term Investments | 9.5B |
| PP&E | 79.3B |
| Intangibles | 5.6B |
| Other Non-Current Assets | 13.1B |
| Current Liabilities | 106.4B |
| Accounts Payable | 44.7B |
| Accrued Liabilities | 5.8B |
| Other Current Liabilities | 55.8B |
| Non-Current Liabilities | 49.4B |
| Long-Term Debt | 35.2B |
| Other Non-Current Liabilities | 14.2B |
Balance Sheet
Ulvac Inc
Ulvac Inc
Currency: JPY
| Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
62 684
|
45 713
|
56 434
|
57 074
|
58 557
|
80 694
|
91 545
|
118 040
|
98 399
|
96 334
|
|
| Cash Equivalents |
62 684
|
45 713
|
56 434
|
57 074
|
58 557
|
80 694
|
91 545
|
118 040
|
98 399
|
96 334
|
|
| Total Receivables |
56 202
|
57 337
|
69 708
|
86 362
|
76 792
|
66 283
|
65 970
|
85 806
|
83 017
|
102 789
|
|
| Accounts Receivables |
56 202
|
57 337
|
69 708
|
86 362
|
76 792
|
66 283
|
65 970
|
85 806
|
73 978
|
95 347
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9 039
|
7 442
|
|
| Inventory |
32 133
|
29 462
|
30 217
|
39 080
|
39 773
|
35 104
|
37 158
|
49 439
|
61 960
|
69 499
|
|
| Other Current Assets |
6 884
|
11 104
|
13 326
|
9 510
|
6 840
|
6 904
|
7 857
|
10 562
|
11 904
|
10 224
|
|
| Total Current Assets |
157 903
|
143 616
|
169 685
|
192 026
|
181 962
|
188 985
|
202 530
|
263 847
|
255 280
|
278 846
|
|
| PP&E Net |
65 662
|
60 374
|
60 306
|
64 297
|
65 687
|
65 189
|
66 086
|
64 995
|
69 588
|
79 745
|
|
| PP&E Gross |
65 662
|
60 374
|
60 306
|
64 297
|
65 687
|
65 189
|
66 086
|
64 995
|
69 588
|
79 745
|
|
| Accumulated Depreciation |
108 818
|
107 804
|
111 418
|
116 370
|
118 094
|
123 742
|
129 773
|
136 306
|
140 319
|
145 876
|
|
| Intangible Assets |
4 625
|
3 916
|
3 573
|
3 454
|
3 446
|
3 278
|
3 496
|
3 715
|
4 336
|
5 403
|
|
| Long-Term Investments |
4 718
|
5 359
|
5 763
|
26 944
|
17 488
|
15 529
|
11 110
|
10 789
|
14 037
|
14 293
|
|
| Other Long-Term Assets |
9 440
|
6 296
|
5 979
|
10 697
|
13 719
|
9 369
|
9 539
|
10 958
|
10 233
|
10 366
|
|
| Total Assets |
242 348
N/A
|
219 561
-9%
|
245 306
+12%
|
297 418
+21%
|
282 302
-5%
|
282 350
+0%
|
292 761
+4%
|
354 304
+21%
|
353 474
0%
|
388 653
+10%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
33 816
|
35 303
|
48 829
|
55 566
|
40 748
|
31 439
|
36 073
|
55 030
|
47 336
|
46 340
|
|
| Accrued Liabilities |
2 134
|
2 574
|
3 139
|
3 697
|
4 110
|
3 058
|
3 403
|
6 322
|
5 440
|
7 350
|
|
| Short-Term Debt |
55 510
|
31 138
|
19 491
|
14 331
|
7 055
|
3 266
|
2 969
|
3 333
|
4 804
|
4 581
|
|
| Current Portion of Long-Term Debt |
7 719
|
8 634
|
11 023
|
7 508
|
8 166
|
8 666
|
6 261
|
6 964
|
7 972
|
9 344
|
|
| Other Current Liabilities |
28 098
|
28 501
|
33 472
|
37 727
|
34 422
|
25 856
|
29 113
|
45 113
|
41 202
|
48 763
|
|
| Total Current Liabilities |
127 277
|
106 150
|
115 954
|
118 829
|
94 501
|
72 285
|
77 819
|
116 762
|
106 754
|
116 378
|
|
| Long-Term Debt |
20 362
|
23 783
|
13 220
|
14 757
|
21 219
|
40 576
|
33 304
|
32 472
|
33 117
|
36 766
|
|
| Deferred Income Tax |
1 590
|
1 399
|
1 408
|
22
|
16
|
27
|
42
|
128
|
195
|
473
|
|
| Minority Interest |
5 559
|
5 133
|
6 229
|
6 538
|
6 676
|
6 840
|
6 800
|
7 508
|
6 641
|
7 297
|
|
| Other Liabilities |
8 191
|
10 197
|
9 807
|
9 741
|
8 978
|
8 369
|
7 897
|
8 458
|
8 555
|
7 309
|
|
| Total Liabilities |
162 979
N/A
|
146 662
-10%
|
146 618
0%
|
149 887
+2%
|
131 390
-12%
|
128 097
-3%
|
125 862
-2%
|
165 328
+31%
|
155 262
-6%
|
168 223
+8%
|
|
| Equity | |||||||||||
| Common Stock |
25 873
|
20 873
|
20 873
|
20 873
|
20 873
|
20 873
|
20 873
|
20 873
|
20 873
|
20 873
|
|
| Retained Earnings |
34 609
|
50 813
|
73 801
|
107 238
|
120 985
|
126 571
|
137 573
|
152 514
|
160 563
|
175 417
|
|
| Additional Paid In Capital |
11 435
|
4 582
|
3 912
|
3 912
|
3 912
|
3 912
|
3 912
|
3 912
|
3 912
|
3 912
|
|
| Unrealized Security Profit/Loss |
718
|
130
|
491
|
14 950
|
6 652
|
5 301
|
2 174
|
1 440
|
2 036
|
1 928
|
|
| Treasury Stock |
10
|
10
|
271
|
266
|
247
|
349
|
343
|
344
|
345
|
257
|
|
| Other Equity |
6 744
|
3 489
|
118
|
824
|
1 263
|
2 055
|
2 710
|
10 581
|
11 173
|
18 557
|
|
| Total Equity |
79 369
N/A
|
72 899
-8%
|
98 688
+35%
|
147 531
+49%
|
150 912
+2%
|
154 253
+2%
|
166 899
+8%
|
188 976
+13%
|
198 212
+5%
|
220 430
+11%
|
|
| Total Liabilities & Equity |
242 348
N/A
|
219 561
-9%
|
245 306
+12%
|
297 418
+21%
|
282 302
-5%
|
282 350
+0%
|
292 761
+4%
|
354 304
+21%
|
353 474
0%
|
388 653
+10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
49
|
49
|
49
|
49
|
49
|
49
|
49
|
49
|
49
|
49
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
